CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Black Diamond Therapeutics, Inc. (BDTX) on Monday reported a loss of $23 million in its third quarter.
The Cambridge, Massachusetts-based company said it had a loss of 45 cents per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 49 cents per share.
Advertisement
The company's shares closed at $1.90. A year ago, they were trading at $2.21.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BDTX at https://www.zacks.com/ap/BDTX